![]() |
市場調查報告書
商品編碼
1479968
血型鑑定產業的全球市場,到2028年的預測Global Blood Group Typing Industry, Forecast to 2028 |
基本試劑和自動化的進步推動革命性變革並加速成長機會
這項研究概述了全球血型分型產業。由於社會意識增強、衛生基礎設施改善、政府措施和人均收入增加等因素,預計將顯著成長。鐮狀貧血、地中海貧血、淋巴瘤、白血病和血友病等血液相關疾病的盛行率不斷增加,也支持了血型檢測的發展。包括自動分析儀和抗球蛋白篩檢工具在內的技術進步徹底改變臨床結果並改善血液相容性。主要市場參與者優先考慮研發(R&D)投資,以提供創新設備、提高安全性、延長保存期限並推動產業成長。在這個競爭環境中,策略夥伴關係和聯盟變得越來越普遍,使產業參與企業能夠擴大其產品範圍並提高其全球影響力。
本研究依地區(北美、歐洲、亞太地區、世界其他地區)、測試類型(ABO 血液檢測和 Rh 分型、抗體篩檢、 HLA型檢測、抗原分型等)和最終用戶(醫院、血液檢測)分析資料。分析該行業的促進因素和限制因素,並確定相關人員和市場相關人員可以利用該行業變化帶來的成長機會。基準年為2023年,預測期間為2024年至2028年。
Advancements in Essential Reagents and Automation are Driving Revolutionary Change and Boosting Growth Opportunities
This study provides an overview of the global blood group typing industry, which is expected to witness significant growth, driven by factors like increased public awareness, improved healthcare infrastructure, government initiatives, and rising per capita income. The increasing prevalence of diseases associated with blood, such as sickle cell anemia, thalassemia, lymphoma, leukemia, and hemophilia, is also supporting the growth of blood group typing. Technological advances, including automated analyzers and antiglobulin screening tools, are revolutionizing clinical outcomes and enhancing blood compatibility. Major market players are prioritizing research and development (R&D) investments to offer innovative devices, improve safety, enhance storage duration, and promote industry growth. Strategic partnerships and alliances are becoming more popular in this competitive environment, allowing industry participants to broaden their product offerings and improve their worldwide presence.
The study offers relevant forecasts for this industry by region (North America, Europe, Asia-Pacific, and the rest of the world), test type (ABO blood tests & Rh typing, antibody screening, HLA typing, antigen typing, and others), and end users (hospitals, blood banks, clinical laboratories, and others). It analyzes the factors driving and restraining this industry and identifies the growth opportunities emerging from the changes in this space for stakeholders and market players to leverage. The base year is 2023, and the forecast period is from 2024 to 2028.